7,8 It included the usual high-risk secondary prevention group with established cardiovascular disease (n=6,974), but also a large primary prevention group (n=10,186) of patients with multiple risk factors: type 2 diabetes and one additional risk factor being dyslipidaemia, hypertension or current tobacco use
Disclosures The trial was funded by the Research Foundation, Mental Health Services, Capital Region of Denmark
In most cases, yesappealing almost always makes sense
Exploring Alternatives and Complementary Therapies If tirzepatide remains ineffective despite best efforts, healthcare providers may explore alternative medications or complementary therapies
The sections were then incubated with streptavidin-fluorescein isothiocyanate (FITC) solution (1:20 dilution) for 30 min at room temperature